Core Portfolio

  • WuXi AppTec

    Leading global integrated life science services platform


    Global leader in ultra-deep gene sequencing for early detection of cancer

  • WuXi NextCode

    World-leading genomic information company for generating, organizing, mining, sharing and applying genomic data

  • DNAnexus

    World-leading cloud solutions for the global genomics industry

  • Adaptimmune

    Global leader in T-cell receptor (TCR) technology to treat solid tumors

  • Hua Medicine

    Global first-in-class GKA-based drug to treat Type II diabetes

  • Synlogic

    Innovative living medicines to patients by using the tools and principles of synthetic biology to genetically re-program beneficial bacteria

  • MedTech (Acquired by Zimmer Biomet)

    Global leader in brain and spine surgical robots

  • Tesaro (Exited - Announced acquisition by GSK on Dec 3, 2018)

    World's new best-in-class drug for ovarian cancer

  • Shockwave

    World-leading device for cardiovascular diseases

  • NxThera (Acquired by Boston Scientific)

    World-leading innovative device to treat urological disorders

  • Sonendo

    Global leader in innovative dentistry (root canal treatment) (*Invested and managed by the ABG Team through an affiliate)

  • Vifor

    Global leader in drugs for iron deficiency and nephrology

  • Quantum Surgical

    Global leader in innovative surgical robots for interventional oncology

  • Pulmonx

    Global leader in minimally invasive treatment for interventional pulmonology

  • WuXi AppTec

    WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with global operations.

  • Shandong Luoxin Pharmaceutical Group

    Shandong Luoxin Pharmaceutical Group is a large-scale pharmaceutical enterprise group integrating drug research and development, manufacturing, trading with medical treatment and health services.

  • Hua Medicine

    Hua Medicine is a leading clinical-stage, innovative drug development company in China, focusing on novel therapies for the treatment of diabetes and CNS disorders.

  • Mega

    Mega Dental is a leading dental product company in China that manufactures and sells restorative and prosthetics dental products, including dentures, veneers, crowns and bridges.

  • LinkDoc

    LinkDoc Technology Limited is a leading oncology big data company, based in Beijing, China. The company has established partnerships with more than 200 of China's top oncology hospitals for the collection, collation and analysis of cancer patients' medical records and clinical data. To-date the company has built a cloud-based repository of more than 400,000 oncology medical records covering all types of cancers.

  • LifeTech Scientific

    LifeTech Scientific Corporation (Stock Code: 1302.HK) is the leading supplier of minimally invasive interventional medical devices to treat cardiovascular and peripheral vascular diseases. (*Invested and managed by the ABG Team through an affiliate)

  • BeiGene

    BeiGene is a commercial-stage biopharmaceutical company rooted in China that is dedicated to becoming a global leader in the discovery, development and commercialization of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer

  • Tasly Biopharma

    Tasly Biopharmam, the biopharma unit of Tasly Pharmaceutical Group (A-Share Listed), has launched one drug aimed at treating blood-clot induced heart attacks (pro-UK) in China and is also in the process of developing more than 10 other drugs.

  • I-Mab Biopharma

    I-Mab Biopharma is a biotech company focusing on innovative biologics in therapeutic areas of immuno-oncology and immuno-inflammation

  • Innovent Biologics

    Innovent Biologics, Inc. is a leading biotech company in China. Innovent aims to produce highly complex biopharmaceutical products that will be affordable to people in China and around the world.

  • Akesobio

    Akesobio is a leading biotech company in China, focusing on discovering and developing innovative therapeutic antibodies with global intellectual property rights for the treatment of a broad spectrum of diseases


    GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is using the power of high-intensity sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop and commercialize pioneering products for the early detection of cancer.

  • Tesaro (Exited - Announced acquisition by GSK on Dec 3, 2018)

    TESARO is a biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer.

  • DNAnexus

    DNAnexus provides a global network for sharing and management of genomic data and tools to accelerate genomics. The DNAnexus cloud-based platform is optimized to address the challenges of security, scalability, and collaboration, for organizations that are pursuing genomic-based approaches to health, in the clinic and in the research lab.

  • Aerpio Pharmaceuticals

    Aerpio Pharmaceuticals is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases.

  • Shockwave Medical

    Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease, creating new opportunities for patients and physicians by effectively targeting calcified plaque.

  • Sonendo

    Sonendo, Inc. provides root canal therapy services for endodontic problems to patients. ( *Managed by ABG's affiliate)

  • Synlogic

    Synlogic is powering a new class of living, Synthetic Biotic™ medicines.

  • Sorrento

    Sorrento is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. Sorrento’s lead products are multiple late-stage biosimilar and biobetter antibodies as well as clinical CAR-T therapies targeting solid tumors.

  • Axonics Modulation (IPO in U.S. NASDAQ on Oct 31, 2018)

    Axonics Modulation (NASDAQ:AXNX) is a medtech company focused on the development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR.

  • Vapotherm

    Innovative respiratory support device - its proprietary Hi-VNI Technology delivers noninvasive ventilatory support to patients through a comfortable small-bore nasal interface

  • Pulmonx

    Pulmonx is a medtech company focused on developing life-changing technologies that improve the lives of patients suffering from COPD. Its innovative product, Zephyr Valve, is the first minimally-invasive device approved by the US FDA for treating patients with severe emphysema

  • Vifor Pharma

    Vifor Pharma Group, formerly Galenica Group, is a global specialty pharmaceuticals company that researches, develops, produces and markets its own pharmaceutical products and is the partner of choice for innovative, patient-focused solutions.

  • Adaptimmune

    Adaptimmune, a leader in T-cell therapy to treat cancer, has multiple trials ongoing in both solid tumours and hematologic cancer types, and in cancers where survival rates for patients can be very limited.

  • Quantum Surgical

    Founded in 2017, Quantum Surgical is a next-generation surgical robotics start-up founded by Bertin Nahum, a serial entrepreneur and founder of Medtech SA. The Company is building next-generation smart tools for minimally invasive therapies, beginning with interventional oncology.